Newport Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,601
Closed -$4.53M 53
2021
Q3
$4.53M Sell
19,601
-5,732
-23% -$1.41M 0.01% 53
2021
Q2
$5.82M Sell
25,333
-2,727
-10% -$548K 0.01% 53
2021
Q1
$5.24M Sell
28,060
-5,291
-16% -$1.03M 0.01% 51
2020
Q4
$5.63M Sell
33,351
-4,191
-11% -$626K 0.02% 51
2020
Q3
$5.56M Sell
37,542
-508
-1% -$78.6K 0.02% 46
2020
Q2
$6.25M Sell
38,050
-78
-0.2% -$12K 0.02% 44
2020
Q1
$5.29M Sell
38,128
-4,445
-10% -$611K 0.02% 46
2019
Q4
$5.6M Sell
42,573
-159,076
-79% -$18.4M 0.02% 47
2019
Q3
$22.6M Sell
201,649
-30,619
-13% -$3.41M 0.06% 42
2019
Q2
$25.7M Sell
232,268
-24,013
-9% -$2.83M 0.07% 38
2019
Q1
$33.3M Buy
256,281
+170,036
+197% +$20.7M 0.1% 35
2018
Q4
$9.98M Buy
+86,245
New +$9.63M 0.03% 41

Other funds holding LLY

Newport Trust Company's LLY Position: Q4 2021 in Review

Newport Trust Company sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 19,601 shares — an estimated $4.53M sold.

Newport Trust Company first reported a position in LLY in Q4 2018 and held it in 12 quarters. The position peaked at $33.3M in Q1 2019. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Newport Trust Company reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • Newport Trust Company sold 19,601 Eli Lilly shares in Q4 2021, an estimated $4.53M.
  • Newport Trust Company first reported a position in Eli Lilly in Q4 2018 and held it in 12 quarters.
  • Newport Trust Company's Eli Lilly position peaked at $33.3M in Q1 2019.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Newport Trust Company's 13F filing for Q4 2021, filed 11 Feb 2022.